- Home
- Forums
- Groups
- Maps
- Resources
- We Have / We Need
- Cholera
- Water Filtration - Homemade ORS
- CTC - Development and Operation
- Cholera - Clinical Presentation and Management
- Cholera Kit - Medical Supplies Guidelines
- Haiti Cholera Training Materials
- Origins of Epidemic
- Posters - Clinical Presentation and Management
- Video - The Story of Cholera - Andeyo Version
- Video - The Story of Cholera - English
- Video - The Story of Cholera - Haitian Creole
- Archive
You are here
Future COVID shots should target JN.1, KP.2 subvariants --US FDA staff
Primary tabs
Future COVID shots should target JN.1, KP.2 subvariants --US FDA staff
Mon, 2024-06-03 10:12 — mike kraft

The FDA reviewers said since the difference between JN.1 and newer subvariants such as KP.2 subvariants is not much, it is possible that vaccines developed against JN.1 may adequately protect against KP.2.
But, the reviewers added that further evolution of the virus could take it away from JN.1, so vaccine makers may need to consider updating their vaccine to the currently predominant variant....
Country / Region Tags:
General Topic Tags:
Problem, Solution, SitRep, or ?:
Groups this Group Post belongs to:
- Private group -
Recent Comments